Example: Heart Attack

Search clinical trials for: Norgestimate

Total 160 results

NCT04423068

Not yet recruiting

Inpatient Adolescent Contraception

Conditions: Pregnancy Related; Contraception; Contraceptive Usage; Contraception Behavior; Pregnancy
NCT04172987

Recruiting

A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female Participants

Conditions: Healthy
NCT04168723

Recruiting

TQT2 Study to Evaluate the Effect of MD1003 on Cardiac Repolarization in Healthy Adult Subjects

Conditions: Healthy Volunteers
NCT04019652

Completed

The Effect of CS-3150 Exposure on Corrected QT (QTc) Interval Duration in Healthy Volunteers

Conditions: Hypertension; Mineralocorticoid Receptor Antagonist
NCT03958123

Completed

Evaluation of the Effects of Multiple Doses of Cebranopadol on the Electrical Activity of the Heart in Healthy Subjects

Conditions: Prolonged QTc Interval; Pharmacokinetic
NCT03951402

Completed

Effect of a Multiple-dose Oral Administration of CG5503 PR on the Electrical Activity of the Heart in 48 Healthy Men and Women

Conditions: Prolonged QTc Interval; Pharmacokinetic
NCT03808298

Completed

Study to Investigate the Effect of Balovaptan on the QTC Interval in Healthy Subjects

Conditions: Healthy Volunteers
NCT03783897

Completed

A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects

Conditions: NASH - Nonalcoholic Steatohepatitis
NCT03696459

Completed

A Study to Evaluate the Effect of JNJ-53718678 on the Cardiac Repolarization Interval in Healthy Adult Participants

Conditions: Healthy
NCT03634852

Completed

A Two Chemoprophylaxis Approaches After Phacoemulsification Surgery

Conditions: Endophthalmitis Postoperative
NCT03606057

Completed

A Study to Investigate the Effect of JNJ-64565111 on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Adults: a Thorough ECG Study Employing Placebo, JNJ-64565111, and a Positive Control (Moxifloxacin)

Conditions: Healthy
NCT03580473

Recruiting

Efficacy and Safety of Saturno IIB Association on the Control of Ocular Inflammation Post-phacoemulsification

Conditions: Ocular Inflammation; Cataract
NCT03554304

Completed

Evaluate the Effect of WCK 5222 on the QT/QTc Interval in Healthy Volunteers

Conditions: QT/QTc Interval in Healthy Volunteers
NCT03494907

Completed

A Study to Evaluate the Effects of Single-dose Seltorexant on Electrocardiogram Intervals in Healthy Adult Participants

Conditions: Healthy
NCT03405168

Completed

Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer

Conditions: Advanced Breast Cancer; Antibiotic; Stable Disease With a Trend of Progression
NCT03357640

Unknown status

Are the Combined Oral Contraceptive Pills Needed for Management of the Simple Ovarian Cysts in Reproductive Women?

Conditions: Ovary Cyst
NCT03280004

Recruiting

Reason Evaluation of Initial Treatment Failure in Patients With CAP

Conditions: Community-acquired Pneumonia
NCT03155893

Completed

A Study to Evaluate the Cardiac Safety of a Single Dose of AL-335 Administered on a Background of Simeprevir and Odalasvir and of Repeated Doses of Odalasvir Administered Alone in Healthy Participants

Conditions: Healthy
NCT02922348

Withdrawn

Hormone Replacement for Premature Ovarian Insufficiency

Conditions: Primary Ovarian Insufficiency
NCT02792517

Completed

Erenumab (AMG 334) Plus Combined Oral Contraceptive Drug Interaction Study in Healthy Females

Conditions: Headache, Migraine
NCT02770729

Terminated

Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis.

Conditions: Endophthalmitis
NCT02658825

Completed

A Study to Evaluate the Effect of JNJ-63623872 on Cardiac Repolarization Interval in Healthy Participants

Conditions: Healthy
NCT02533427

Completed

Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol

Conditions: HCV Infection
NCT02515864

Completed

Clinical Pharmacology of FYU-981 (Effect on QT/QTc Interval)

Conditions: Healthy
NCT02494609

Unknown status

Oral Contraceptive DDI Study

Conditions: Healthy
NCT02373280

Recruiting

The Efficacy of the 7 Days Tailored Therapy as the 1st Eradication of H. Pylori Infection

Conditions: Helicobacter Infection
NCT02307864

Completed

Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants

Conditions: Healthy
NCT02293148

Completed

Single Dose, Pharmacokinetic, Safety, Tolerability and QTc Study of GSK1278863 in Healthy Volunteers

Conditions: Anaemia
NCT02271438

Completed

A Study to Evaluate the Effects of Ibrutinib on Cardiac Repolarization in Healthy Participants

Conditions: Healthy
NCT02262546

Completed

Influence of Pramipexole on the QT Interval of the ECG in Healthy Male and Female Volunteers

Conditions: Healthy
NCT02257398

Completed

Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers

Conditions: Infections, Respiratory Tract
NCT02243241

Completed

The Effect of Hydrocodone Bitartrate (HYD) Extended-Release Tablets on QT /QTc Intervals in Healthy Adult Subjects

Conditions: Healthy
NCT02206204

Completed

Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects

Conditions: Cardiodynamics; Safety; Tolerability; Pharmacokinetics
NCT02165332

Completed

A Two-part, Single-dose, Randomized Study to Evaluate the Safety of Supra-therapeutic Doses of RO7033877 and to Investigate the Effect of RO7033877 on the QTc Interval

Conditions: Healthy Volunteer
NCT02157467

Completed

Study of Combined Oral Contraceptive Effects in Female Subjects

Conditions: Infection, Human Immunodeficiency Virus
NCT02152332

Completed

A Study to Evaluate the Effects of JNJ-54861911 on Electrocardiogram Intervals in Healthy Particiants

Conditions: Healthy
NCT02144246

Terminated

Contraceptive Hormones and Women With Cystic Fibrosis

Conditions: Cystic Fibrosis Exacerbations While on and Off Hormonal Contraception
NCT02136888

Completed

Study of the Electrocardiographic Effects of Ponesimod in Healthy Male and Female Subjects

Conditions: Healthy
NCT02128308

Completed

Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents

Conditions: Healthy
NCT02127593

Completed

A Bioequivalence Study of Norgestimate /Ethinyl Estradiol (NGM/EE) Tablets Manufactured at 2 Different Facilities

Conditions: Healthy
NCT02104648

Completed

A 2-Part Study to Evaluate the Safety of Supra-Therapeutic Doses of RO4602522 and to Investigate the Effect of RO4602522 on the QTc Interval

Conditions: Healthy Volunteer
NCT02099240

Unknown status

Patients Response to Early Switch To Oral:Osteomyelitis Study

Conditions: Osteomyelitis
NCT02080468

Completed

Evaluate the Effect of Ethinyl Estradiol/Norgestimate on the Pharmacokinetics of Lomitapide in Healthy Female Subjects

Conditions: Healthy
NCT02068170

Completed

Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital

Conditions: Delirium; QT-prolongation
NCT01999114

Completed

The Effect of Buprenorphine Delivered by Buprenorphine Transdermal System (BTDS) at Doses up to 80 Micrograms/Hour (mcg/hr) and Naltrexone on Electrocardiogram (ECG) Intervals in Healthy Volunteers

Conditions: ECG Effects
NCT01928693

Terminated

A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers.

Conditions: Corneal Ulcers
NCT01910415

Completed

Phase 1, QT/QTC Interval Study in Healthy Subjects

Conditions: Cystic Fibrosis
NCT01871701

Completed

Clinical Trial to Investigate the Effect on Corrected QT Interval Prolongation by Psychotropic Drugs

Conditions: Healthy
NCT01756495

Completed

A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and Moxifloxacin

Conditions: Acute Coronary Syndrome
NCT01746732

Completed

A Study of Evacetrapib in Healthy Female Participants

Conditions: Healthy Volunteers